These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 7394336)
1. Studies on the effects of glucagon on ouabain-induced cardiac disorders using the PISA method. Gupta MM; Prasad K Adv Myocardiol; 1980; 1():313-9. PubMed ID: 7394336 [TBL] [Abstract][Full Text] [Related]
2. Effect of glucagon on arrhythmias induced by coronary artery occlusion and ouabain in dogs. Singh J; Bala S; Kaur AH; Garg KN Indian J Physiol Pharmacol; 1980; 24(4):329-34. PubMed ID: 7216388 [TBL] [Abstract][Full Text] [Related]
3. Glucagon-induced cardiac effects following normal and toxic doses of ouabain. Denney DL; Daniell HB Arch Int Pharmacodyn Ther; 1971 May; 191(1):111-9. PubMed ID: 5557388 [No Abstract] [Full Text] [Related]
4. Phase-invariant signature algorithm: a noninvasive technique for early detection and quantification of ouabain-induced cardiac disorders. Prasad K; Gupta MM Angiology; 1979 Nov; 30(11):721-32. PubMed ID: 507458 [No Abstract] [Full Text] [Related]
6. Characterization of the acute cardiac electrophysiologic effects of ethanol in dogs. Fenelon G; Balbão CE; Fernandes R; Arfelli E; Landim P; Ayres O; Paola AA Alcohol Clin Exp Res; 2007 Sep; 31(9):1574-80. PubMed ID: 17624995 [TBL] [Abstract][Full Text] [Related]
7. The effect of glucagon on arrhythmias due to digitalis toxicity. Cohn KE; Agmon J; Gamble OW Am J Cardiol; 1970 Jun; 25(6):683-9. PubMed ID: 4192693 [No Abstract] [Full Text] [Related]
8. Antiarrhythmic activity of four pteridine compounds in ouabain intoxication. Yeh BK; Francis JS; Gosselin AJ; Elias RA Clin Pharmacol Ther; 1975 Feb; 17(2):141-5. PubMed ID: 235395 [TBL] [Abstract][Full Text] [Related]
9. [Triggered activities in cat heart induced by combined administration of ouabain and calcium gluconate]. Yu WG; Xie JT Zhongguo Yao Li Xue Bao; 1993 May; 14(3):249-52. PubMed ID: 8237403 [TBL] [Abstract][Full Text] [Related]
10. Effect of ouabain in catecholamine-induced cardiac hypertrophy. Mészáros J; Pásztor B Acta Physiol Hung; 1995; 83(1):55-62. PubMed ID: 7660838 [TBL] [Abstract][Full Text] [Related]
11. PISA--a new noninvasive method for early detection and quantification of heart disease. Prasad K; Gupta MM Adv Myocardiol; 1980; 1():287-312. PubMed ID: 7394335 [No Abstract] [Full Text] [Related]
12. Correlation of ouabain-induced arrhythmia and nonuniformity in the histamine-evoked discharge of cardiac sympathetic nerves. Lathers CM; Roberts J; Kelliher GJ J Pharmacol Exp Ther; 1977 Nov; 203(2):467-79. PubMed ID: 909075 [No Abstract] [Full Text] [Related]
13. [A method for the production of digitalic arrhythmia in dogs]. Duchêne-Marullaz P; Cosnier D; Grimal J C R Seances Soc Biol Fil; 1971; 165(9):1910-3. PubMed ID: 4116487 [No Abstract] [Full Text] [Related]
14. Interactions of quazodine with cardiotoxic doses of ouabain in the anesthetized dog. Gomoll AW; Byrne JE; McKinney GR Arch Int Pharmacodyn Ther; 1974 Jan; 207(1):16-27. PubMed ID: 4151046 [No Abstract] [Full Text] [Related]
15. Time course of effect of piperazine citrate on the electrocardiogram of the rat. Ghasi S; Onuaguluchi G Am J Ther; 2007; 14(6):524-32. PubMed ID: 18090878 [TBL] [Abstract][Full Text] [Related]
16. Phentolamine: use in digitalis-induced arrhythmias. Canine experiments. Ettinger S; Gould L; Carmichael JA; Tashjian RJ Am Heart J; 1969 May; 77(5):636-40. PubMed ID: 5778053 [No Abstract] [Full Text] [Related]
17. Electrophysiological effects of direct current countershock before and after ouabain sensitization and after diphenylhydantoin desensitization in the dog. Helfant RH; Scherlag BJ; Damato AM Circ Res; 1968 May; 22(5):615-23. PubMed ID: 5648065 [No Abstract] [Full Text] [Related]
18. PISA--a noninvasive method in the evaluation of protective effect of methylprednisolone on the ischemic myocardium. Prasad K; Gupta MM; Yu J J Cardiovasc Surg (Torino); 1983; 24(6):610-21. PubMed ID: 6654972 [TBL] [Abstract][Full Text] [Related]
19. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs. Sen L; Cui G; Sakaguchi Y; Singh BN J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614 [TBL] [Abstract][Full Text] [Related]